Published in BMC Cancer on January 27, 2014
Resistance to multikinase inhibitor actions mediated by insulin like growth factor-1. J Exp Clin Cancer Res (2015) 0.81
Postoperative Low Absolute Lymphocyte Counts may Predict Poor Outcomes of Hepatocellular Carcinoma After Liver Resection. Chin Med J (Engl) (2016) 0.81
Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence. World J Gastroenterol (2015) 0.78
Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor. Cancer Chemother Pharmacol (2015) 0.77
Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis. World J Gastroenterol (2015) 0.77
Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma. World J Gastroenterol (2015) 0.76
Stratified Platelet-to-lymphocyte Ratio: A Novel Target for Prognostic Prediction of Hepatocellular Carcinoma after Curative Liver Resection. J Clin Transl Hepatol (2017) 0.75
Prognostic value of inflammation-based markers in patients with recurrent malignant obstructive jaundice treated by reimplantation of biliary metal stents: A retrospective observational study. Medicine (Baltimore) (2017) 0.75
Soluble MICB protein levels and platelet counts during hepatitis B virus infection and response to hepatocellular carcinoma treatment. BMC Infect Dis (2015) 0.75
The Antiproliferative Effect of Chakasaponins I and II, Floratheasaponin A, and Epigallocatechin 3-O-Gallate Isolated from Camellia sinensis on Human Digestive Tract Carcinoma Cell Lines. Int J Mol Sci (2016) 0.75
Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6. Sci Rep (2017) 0.75
A Liver Index and its Relationship to Indices of HCC Aggressiveness. J Integr Oncol (2016) 0.75
Targeting Platelets for the Treatment of Cancer. Cancers (Basel) (2017) 0.75
Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell (2011) 6.21
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet (2012) 4.85
Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med (2012) 3.54
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci U S A (2012) 3.50
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol (2012) 3.37
Platelet-derived serotonin mediates liver regeneration. Science (2006) 2.98
Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A (1968) 2.95
THROMBOCYTOSIS ASSOCIATED WITH MALIGNANT DISEASE. Arch Intern Med (1964) 2.26
The platelet contribution to cancer progression. J Thromb Haemost (2011) 2.16
A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. Cancer Res (2005) 1.87
Cell biology. Beyond clotting: the powers of platelets. Science (2010) 1.64
Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther (2013) 1.56
Tumor-platelet interaction in solid tumors. Int J Cancer (2012) 1.54
The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther (2008) 1.38
Targeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse models. PLoS One (2012) 1.15
Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: growth inhibition, quiescence, and recovery. J Cell Physiol (2013) 1.14
PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells. Neoplasia (2013) 1.11
Acyclic retinoid targets platelet-derived growth factor signaling in the prevention of hepatic fibrosis and hepatocellular carcinoma development. Cancer Res (2012) 1.09
Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production. Int J Cancer (2009) 1.08
Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus. J Cancer Res Clin Oncol (2000) 1.06
Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma. Oncology (2012) 1.03
The platelet-cancer loop. Eur J Intern Med (2013) 1.02
Characterization of the cytokine profile of platelet rich plasma (PRP) and PRP-induced cell proliferation and migration: Upregulation of matrix metalloproteinase-1 and -9 in HaCaT cells. Korean J Hematol (2011) 1.01
Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg (2011) 0.98
Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells. Hepatology (2002) 0.98
Aspirin induces apoptosis in vitro and inhibits tumor growth of human hepatocellular carcinoma cells in a nude mouse xenograft model. Int J Oncol (2011) 0.97
Platelet-rich plasma therapy - future or trend? Arthritis Res Ther (2012) 0.94
Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis. Clin Exp Metastasis (2009) 0.94
Thrombocytosis and hepatocellular carcinoma. Dig Dis Sci (2013) 0.94
Serotonin promotes the proliferation of serum-deprived hepatocellular carcinoma cells via upregulation of FOXO3a. Mol Cancer (2013) 0.91
Activation of human liver sinusoidal endothelial cell by human platelets induces hepatocyte proliferation. J Hepatol (2010) 0.90
Role and regulation of PDGFRα signaling in liver development and regeneration. Am J Pathol (2013) 0.89
Features of massive hepatocellular carcinomas. Eur J Gastroenterol Hepatol (2014) 0.87
Platelets promote the adhesion of human hepatoma cells with a highly metastatic potential to extracellular matrix protein: involvement of platelet P-selectin and GP IIb-IIIa. J Cancer Res Clin Oncol (2002) 0.85
Platelet activation during tumor development, the potential role of BDNF-TrkB autocrine loop. Biochem Biophys Res Commun (2006) 0.84
Platelets Strongly Induce Hepatocyte Proliferation with IGF-1 and HGF In Vitro. J Surg Res (2007) 0.84
Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma. Jpn J Cancer Res (2002) 0.82
Platelet activation and vascular endothelial growth factor 165 release in hepatocellular cancer. Clin Chim Acta (2010) 0.78
Dissection of DEN-induced platelet proteome changes reveals the progressively dys-regulated pathways indicative of hepatocarcinogenesis. J Proteome Res (2010) 0.78
Regulation of signal transduction and role of platelets in liver regeneration. Int J Hepatol (2012) 0.76
Hsp90 prevents phenotypic variation by suppressing the mutagenic activity of transposons. Nature (2010) 2.44
Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma. Hepatology (2009) 1.27
Inhibiting TGF-β signaling in hepatocellular carcinoma. Biochim Biophys Acta (2010) 1.20
Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: growth inhibition, quiescence, and recovery. J Cell Physiol (2013) 1.14
Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. PLoS One (2013) 1.06
Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells. Oncogene (2004) 1.04
Effects of low concentrations of regorafenib and sorafenib on human HCC cell AFP, migration, invasion, and growth in vitro. J Cell Physiol (2013) 1.04
REST: an oncogene or a tumor suppressor? Trends Cell Biol (2013) 0.98
Up-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in left-sided human colon cancer. Anticancer Res (2005) 0.98
Expression analysis of a subset of coregulators and three nuclear receptors in human colorectal carcinoma. Anticancer Res (2005) 0.97
Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters. Toxicol Lett (2005) 0.94
Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines. Immunopharmacol Immunotoxicol (2009) 0.94
Rapid neurite outgrowth in neurosecretory cells and neurons is sustained by the exocytosis of a cytoplasmic organelle, the enlargeosome. J Cell Sci (2009) 0.92
A signaling loop of REST, TSC2 and β-catenin governs proliferation and function of PC12 neural cells. J Cell Sci (2011) 0.90
PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors. Clin Dev Immunol (2011) 0.89
Structure, regulation and evolution of the crystal-Stellate system of Drosophila. Genetica (2003) 0.89
Astrocyte stellation, a process dependent on Rac1 is sustained by the regulated exocytosis of enlargeosomes. Glia (2011) 0.89
Polyunsaturated fatty acids reduce fatty acid synthase and hydroxy-methyl-glutaryl CoA-reductase gene expression and promote apoptosis in HepG2 cell line. Lipids Health Dis (2011) 0.89
REST/NRSF-mediated intrinsic homeostasis protects neuronal networks from hyperexcitability. EMBO J (2013) 0.88
Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer. Anticancer Res (2013) 0.88
REST/NRSF governs the expression of dense-core vesicle gliosecretion in astrocytes. J Cell Biol (2011) 0.88
Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines. Scand J Gastroenterol (2008) 0.88
Tissue expression of Squamous Cellular Carcinoma Antigen (SCCA) is inversely correlated to tumor size in HCC. Mol Cancer (2009) 0.88
Effect of genistein on cholesterol metabolism-related genes in a colon cancer cell line. Genes Nutr (2008) 0.87
Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis. Oncology (2004) 0.87
Effects of anandamide on polyamine levels and cell growth in human colon cancer cells. Anticancer Res (2010) 0.87
Effects of genistein on the polyamine metabolism and cell growth in DLD-1 human colon cancer cells. Nutr Cancer (2005) 0.87
Reversibility of regorafenib effects in hepatocellular carcinoma cells. Cancer Chemother Pharmacol (2013) 0.86
3-Hydroxy-3-methylglutaryl coenzyme A reductase activity and low-density lipoprotein receptor expression in diffuse-type and intestinal-type human gastric cancer. J Gastroenterol (2002) 0.86
Synergic effect of eicosapentaenoic acid and lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells. Lipids Health Dis (2010) 0.86
Effects of Lactobacillus rhamnosus GG on the cell growth and polyamine metabolism in HGC-27 human gastric cancer cells. Nutr Cancer (2007) 0.86
Peroxisome proliferator-activated receptor gamma and spermidine/spermine N1-acetyltransferase gene expressions are significantly correlated in human colorectal cancer. BMC Cancer (2006) 0.84
Kinase activation profile associated with TGF-β-dependent migration of HCC cells: a preclinical study. Cancer Chemother Pharmacol (2010) 0.84
DmMyD88 controls dorsoventral patterning of the Drosophila embryo. EMBO Rep (2003) 0.84
Antagonism of sorafenib and regorafenib actions by platelet factors in hepatocellular carcinoma cell lines. BMC Cancer (2014) 0.83
PI3K class IB controls the cell cycle checkpoint promoting cell proliferation in hepatocellular carcinoma. Int J Cancer (2012) 0.83
Distribution of estrogen receptor subtypes, expression of their variant forms, and clinicopathological characteristics of human colorectal cancer. Dig Dis Sci (2002) 0.83
The rest repression of the neurosecretory phenotype is negatively modulated by BHC80, a protein of the BRAF/HDAC complex. J Neurosci (2009) 0.83
KRAS genotyping as biomarker in colorectal cancer: a comparison of three commercial kits on histologic material. Anticancer Res (2010) 0.83
c-Met-Akt pathway-mediated enhancement of inhibitory c-Raf phosphorylation is involved in vitamin K1 and sorafenib synergy on HCC growth inhibition. Cancer Biol Ther (2011) 0.82
The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer. Cancer Causes Control (2014) 0.82
Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells. Scand J Gastroenterol (2005) 0.82
Quercetin inhibits human DLD-1 colon cancer cell growth and polyamine biosynthesis. Anticancer Res (2010) 0.82
A new form of neurite outgrowth sustained by the exocytosis of enlargeosomes expressed under the control of REST. Traffic (2010) 0.81
Involvement of estrogen receptor-related receptors in human ovarian endometriosis. Fertil Steril (2011) 0.81
Assessment of estrogen receptors and apoptotic factors in cryopreserved human ovarian cortex. Syst Biol Reprod Med (2009) 0.81
Frictional purpuric eruption associated with angiotensin II receptor blockers. Dermatol Ther (2013) 0.80
Early induction of LDL receptor gene expression by genistein in DLD-1 colon cancer cell line. Fitoterapia (2008) 0.80
Influence of plasminogen activator inhibitor-1 (SERPINE1) 4G/5G polymorphism on circulating SERPINE-1 antigen expression in HCC associated with viral infection. Cancer Genomics Proteomics (2012) 0.79
N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation. FASEB J (2006) 0.79
Dual REST-dependence of L1CAM: from gene expression to alternative splicing governed by Nova2 in neural cells. J Neurochem (2012) 0.79
Potential role of the steroid receptor pattern in the response of inoperable intra-abdominal desmoid to toremifene after failure of tamoxifen therapy. Int J Colorectal Dis (2009) 0.79
Antiproliferative, antioxidant and anti-inflammatory effects of hydroxytyrosol on human hepatoma HepG2 and Hep3B cell lines. Anticancer Res (2012) 0.78
NGF signaling in PC12 cells: the cooperation of p75(NTR) with TrkA is needed for the activation of both mTORC2 and the PI3K signalling cascade. Biol Open (2013) 0.78
Drug reaction with eosinophilia and systemic symptoms caused by lenalidomide. Eur J Dermatol (2012) 0.78
A significant role of lipogenic enzymes in colorectal cancer. Anticancer Res (2012) 0.78
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin. Oncol Rep (2010) 0.77
N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1. Int J Cancer (2009) 0.77
Modulation of Doxorubicin mediated growth inhibition of hepatocellular carcinoma cells by platelet lysates. Anticancer Agents Med Chem (2014) 0.77
Apoptosis in normal ovaries of women with and without endometriosis. Reprod Biomed Online (2009) 0.76
Reply: To PMID 21674557. Hepatology (2013) 0.75